Table 1.
n | HCV-Seropositive | p-value | |
---|---|---|---|
Study Participants | 387 | 366 (95%) | -- |
Sex | |||
Male | 285 | 273 (96%) | 0.07 |
Female | 101 | 92 (91%) | |
Age | |||
≤25 years | 127 | 119 (94%) | 0.60 |
>25 years | 260 | 247 (95%) | |
Injected in the past 30 days | |||
Yes | 342 | 331 (97%) | <0.01 |
No | 36 | 26 (72%) | |
Age at first injection | |||
≤18 years | 184 | 179 (97%) | 0.02 |
>18 years | 200 | 184 (92%) | |
Duration of injection drug use | |||
≤5 years | 106 | 92 (87%) | <0.01 |
>5 years | 280 | 273 (98%) | |
Number of injections, past 30 days | |||
< 30 / month | 260 | 241 (93%) | 0.03 |
≥30 / month | 118 | 116 (98%) | |
Number injection partners, past 6 months | |||
≤2 | 162 | 150 (93%) | 0.20 |
>2 | 208 | 192 (96%) | |
New injection partner, past 30 days | |||
Yes | 112 | 108 (96%) | 0.20 |
No | 228 | 199 (93%) | |
Unsafe injection, past 30 days | |||
Yes | 253 | 245 (97%) | <0.01 |
No | 112 | 101 (90%) | |
HIV positive | |||
Yes | 193 | 188 (97%) | 0.014 |
No | 194 | 178 (92%) |